APhA-APRS ESAS Colleagues in Research: Getting Personal: The Impact of Pharmacogenomics on Patient Care

Description

Pharmacogenomic testing makes it possible to individualize treatment strategies and improve patient outcomes. However, the application of pharmacogenomic information in the clinical setting is not without its challenges. Join this session to hear experts in pharmacogenomics break out the evidence underlying pharmacogenomic testing, its use in clinical and research settings, and associated ethical implications.

 

Pharmacist Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Describe the evidence supporting the use of pharmacogenomic information in clinical pharmacy practice.
  2. Discuss barriers to implementing pharmacogenomic testing in clinical pharmacy practice.
  3.  Explain effective strategies to overcome barriers to implementing pharmacogenomic testing.
  4. Identify novel implementation strategies that bridge pharmacogenomic research and clinical practice and discuss the ethical implications of pharmacogenomic testing.

 

Technician Learning Objectives

 

 

 
 
 
Speakers:
Meghan
Meghan Arwood, PharmD, MS, BCPS
Clinical Assistant Professor
University of Florida College of Pharmacy
 
Christina
Christina Aquilante, PharmD
Professor
University of Colorado
 
Learning Level: Level 2
Pathway: Day of Science
Track: Integrating Science into Practice
Session Time Slot(s): 
Date: 
Saturday, March 23
Time: 
3:00 PM - 4:30 PM
Room: 
Washington State Convention Center - Room 611-612
ACPE Pharmacist: 0202-0000-19-047-L04-P
CEUs Pharmacist: .15
Activity Type:
Knowledge-based